Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
Titel:
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
Auteur:
Yhim, Ho-Young Lee, Na-Ri Song, Eun-Kee Yim, Chang-Yeol Jeon, So Yeon Shin, Seunghwan Kim, Jeong-A Kim, Hee Sun Cho, Eun Hae Kwak, Jae-Yong